Pathogenicity of novel atypical variants leading to choroideremia as determined by functional analyses.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 07 2018
revised: 15 10 2018
accepted: 16 10 2018
pubmed: 21 10 2018
medline: 7 3 2020
entrez: 21 10 2018
Statut: ppublish

Résumé

Choroideremia is a monogenic X-linked recessive chorioretinal disease linked to pathogenic variants in the CHM gene. These variants are commonly base-pair changes, frameshifts, or large deletions. However, a few rare or unusual events comprising large duplications, a retrotransposon insertion, a pseudo-exon activation, and two c-98 promoter substitutions have also been described. Following an exhaustive molecular diagnosis, we identified and characterized three novel atypical disease-causing variants in three unrelated male patients. One is a first-ever reported Alu insertion within CHM and the other two are nucleotide substitutions, c.-90C>G and c.-108A>G, affecting highly conserved promoter positions. RNA analysis combined with western blot and functional assays of patient cells established the pathogenicity of the Alu insertion and the c.-90C>G alteration. Furthermore, luciferase reporter assays suggested a CHM transcription defect associated with the c.-90C>G and c.-108A>G variants. These findings broaden our knowledge of the mutational spectrum and the transcriptional regulation of the CHM gene.

Identifiants

pubmed: 30341801
doi: 10.1002/humu.23671
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-35

Subventions

Organisme : Asociacion de Afectados por Coroideremia
Pays : International
Organisme : Association Française contre les Myopathies
Pays : International
Organisme : Fédération des Aveugles de France
Pays : International
Organisme : France Choroïdérémie
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Christel Vaché (C)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Simona Torriano (S)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.

Valérie Faugère (V)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Nejla Erkilic (N)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.

David Baux (D)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Gema Garcia-Garcia (G)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Christian P Hamel (CP)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.
Centre de Référence Maladies Sensorielles Génétiques, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Isabelle Meunier (I)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.
Centre de Référence Maladies Sensorielles Génétiques, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Xavier Zanlonghi (X)

Centre de Compétence Maladie Rares, Clinique Pluridisciplinaire Jules Verne, Nantes, France.

Michel Koenig (M)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Vasiliki Kalatzis (V)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.

Anne-Françoise Roux (AF)

Laboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH